Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) saw a significant decline in short interest in the month of January. As of January 31st, there was short interest totalling 6,650,000 shares, a decline of 10.0% from the January 15th total of 7,390,000 shares. Based on an average daily trading volume, of 1,900,000 shares, the short-interest […]
Tyra Biosciences (TYRA) Announces $200M Private Placement streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that.
Carlsbad-based Tyra Biosciences ,a company developing precision medicines for targeting Fibroblast Growth Factor Receptor (FGFR) biology, has raised $200M in a private placement (PIPE). The publicly listed compan
NEW HAVEN, Conn., Nov. 27, 2023 Arvinas, Inc. , a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that it has entered.